Published in J Comput Assist Tomogr on July 02, 1992
Pancreatic schwannoma: Case report and an updated 30-year review of the literature yielding 47 cases. World J Gastroenterol (2012) 1.11
Primary pleural benign myxoid schwannoma in an 18-year-old female: a case report and literature review. Case Rep Oncol Med (2014) 0.98
Rare presentation of pancreatic schwannoma: a case report. J Med Case Rep (2008) 0.97
Pancreatic Schwannoma: report of a case. Surg Today (1999) 0.91
Pancreatic schwannoma: Report of a case and review of literature. Indian J Surg (2010) 0.86
Pancreatic schwannoma: report of a case. Surg Today (2008) 0.86
Pancreatic tail schwannoma in a 44-year-old male: a case report and literature review. Case Rep Oncol Med (2013) 0.86
Central pancreatectomy for pancreatic schwannoma: A case report and literature review. World J Gastroenterol (2016) 0.79
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (1996) 11.13
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg (1997) 8.86
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg (2001) 8.34
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med (2000) 6.27
The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg (1995) 5.95
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg (1995) 5.66
Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg (1987) 5.58
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med (1995) 5.10
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet (1994) 4.63
Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res (1997) 4.54
A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24
Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg (1998) 4.19
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res (2001) 4.19
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg (1997) 3.90
Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg (1991) 3.88
Clinical prediction rule for pulmonary infiltrates. Ann Intern Med (1990) 3.81
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res (2000) 3.74
DPC4 gene in various tumor types. Cancer Res (1996) 3.74
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med (2000) 3.70
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res (1996) 3.60
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56
Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant (1996) 3.51
The natural history of renal angiomyolipoma. J Urol (1993) 3.41
Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med (1995) 3.31
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol (2001) 3.27
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg (1993) 3.17
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res (1997) 3.17
Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg (1996) 3.13
Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg (1999) 3.09
The management of renal angiomyolipoma. J Urol (1986) 3.05
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02
Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg (2000) 2.94
Selective nonoperative management of contained intrathoracic esophageal disruptions. Ann Thorac Surg (1979) 2.90
Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res (1998) 2.89
p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res (1997) 2.88
p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res (1994) 2.80
Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg (2001) 2.80
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. Am J Pathol (2000) 2.63
Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg (1998) 2.60
Chronic pancreatic ascites and pancreatic pleural effusions. Gastroenterology (1978) 2.60
Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol (1999) 2.59
Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg (1997) 2.53
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res (2001) 2.50
Postoperative bile duct strictures: management and outcome in the 1990s. Ann Surg (2000) 2.50
Bacterial renal infection: role of CT. Radiology (1989) 2.49
Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis. Ann Surg (1973) 2.47
Factors affecting mortality in biliary tract surgery. Am J Surg (1981) 2.41
Laparoscopic cholecystectomy-related bile duct injuries: a health and financial disaster. Ann Surg (1997) 2.41
Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res (2000) 2.40
Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg (1999) 2.37
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg (1999) 2.36
Choledochal cyst disease. A changing pattern of presentation. Ann Surg (1994) 2.33
Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg (1998) 2.32
Surgical management of unresectable carcinoma of the pancreas. Surgery (1982) 2.30
Primary vs secondary iliopsoas abscess. Presentation, microbiology, and treatment. Arch Surg (1995) 2.29
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res (1996) 2.29
Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg (1995) 2.28
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res (1994) 2.26
Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg (1993) 2.26
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23
Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg (1999) 2.23
CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment? AJR Am J Roentgenol (2000) 2.22
Cecal volvulus: analysis of 50 patients with long-term follow-up. Ann Surg (1979) 2.13
Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol (2000) 2.12
Allelotype of pancreatic adenocarcinoma. Cancer Res (1994) 2.11
Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol (1989) 2.09
The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res (1993) 2.05
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J Sci Am (1998) 2.03
Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol (1988) 2.03
Imaging of nontraumatic hemorrhage of the adrenal gland. Radiographics (1999) 2.03
Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg (2000) 2.00
Three-dimensional volume rendering of spiral CT data: theory and method. Radiographics (1999) 2.00
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98
Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res (1998) 1.97
Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. Cancer Res (2001) 1.96
The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg (1984) 1.92
Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (2001) 1.89
A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant (1991) 1.87
Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg (2000) 1.86
Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg (1998) 1.83
The natural history of pancreatic pseudocysts documented by computed tomography. Surg Gynecol Obstet (1990) 1.83